Abstract: FR-PO682
Role of Angiotensinogen in Children with a History of Preterm Birth and Nephron Hypertrophy
Session Information
- Pediatric Nephrology - 1
October 25, 2024 | Location: Exhibit Hall, Convention Center
Abstract Time: 10:00 AM - 12:00 PM
Category: Pediatric Nephrology
- 1900 Pediatric Nephrology
Authors
- Ishimori, Shingo, Kobe University Graduate School of Medicine, Kobe, Japan
- Kimura, Yuka, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan
- Kitakado, Hideaki, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan
- Ueda, Chika, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan
- Inoki, Yuta, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan
- Tanaka, Yu, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan
- Fujimura, Junya, Kakogawa Chuo Shimin Byoin, Kakogawa, Hyogo, Japan
- Horinouchi, Tomoko, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan
- Yamamura, Tomohiko, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan
- Sakakibara, Nana, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan
- Nagano, China, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan
- Nozu, Kandai, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan
Background
A history of preterm birth and low birth weight (preterm) is a risk factor for chronic kidney disease, which is primarily characterized by tubulointerstitial damage resulting from a decrease in nephron number and compensatory nephron hypertrophy (NH). While the renin–angiotensin system (RAS) plays a crucial role in renal development, no pathological studies have examined the association between RAS and tubulointerstitial lesions in children with a history of preterm birth.
Methods
We performed immunohistochemical staining of renal biopsy specimens collected from 2000 to 2023. Patients were eligible if they had pathological minimal change (MC) or NH without other types of nephritis, and if the indication for renal biopsy was asymptomatic proteinuria, nephrotic syndrome, or decreased renal function. Immunohistochemical staining of angiotensinogen (AGT) was used as a marker of intrarenal RAS, and angiotensin II was used as a marker of systemic RAS.
Results
We enrolled 36 children with a median age at the renal biopsy of 13.4 years. AGT staining was negative in the glomeruli of children with NH but positive in the renal tubules (Fig. a). The positive area of AGT staining in the renal tubules was significantly correlated with an increase in the average area of a single glomerulus (p<0.01, Fig. b). The positive area of AGT staining in the renal tubules of preterm children with NH (n=8), full-term children with NH (n=5), and preterm children with MC (n=5) was significantly more extensive than that in full-term children with MC (n=18) (65.8, 153.2, and 53.0 μm2 vs 19.4 μm2, all p<0.01; Fig. c). Angiotensin II staining was weakly positive in the renal tubules across all four groups, with no significant difference between the groups.
Conclusion
AGT may play a major role as an indicator of intrarenal RAS in preterm children even before the onset of NH.